Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
KLC1 antisense RNA 1 (KLC1-AS1) is a long non-coding RNA (lncRNA) transcribed from the genomic region antisense to the KLC1 gene, which encodes the kinesin light chain 1 protein. While lncRNAs are increasingly recognized for their roles in regulating gene expression and chromatin states, there is currently limited published information on the specific biological functions, disease associations, or therapeutic interest of KLC1-AS1. It is not categorized as a classical therapeutic target. No drugs are currently known to interact with or modulate this RNA, and it is not widely described as a biomarker or direct disease effector in the literature available[5][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on KLC1 antisense RNA 1 (KLC1-AS1).